Brepocitinib, a potent and selective TYK2/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis

Shieh A, Karlamangla AS, Gossiel F, Eastell R, Burnett-Bowie SA, Greendale GA. Estimating net bone formation relative to resorption using reference bone turnover markers. J[...]

Helminski D, Sussman JB, Pfeiffer PN, Kokaly AN, Ranusch A, Renji AD, Damschroder LJ, Landis-Lewis Z, Kurlander JE. Development, Implementation, and Evaluation Methods for Dashboards[...]

Mahurkar-Joshi S, Thompson M, Villarruel E, Lewis JD, Lin LD, Farid M, Nayeb-Hashemi H, Storage T, Weiss GA, Limketkai BN, Sauk JS, Mayer EA, Chang[...]